BAILLY R JEFFREY sold $4.1M of UFPT (indirect holdings)

BAILLY R JEFFREY (Executive Chairman) sold 13,011 indirectly-held shares of UFP TECHNOLOGIES INC (UFPT) at an average of $316.13 ($315.53–$317.27, $4.11M total) across 3 trades on 2026-08-10.

Original reporting
SEC EDGAR · BAILLY R JEFFREY
Published Aug 11, 2026, 7:38 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Aug 11, 2026, 7:42 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$UFPT
Neutral
medium confidence
Mentioned
$UFPT
Relevance
6/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$UFPTNeutralLow
01

Why it matters

The only new information is the disclosed open-market sale size, timing (Aug 10), price range, and that holdings after the transaction are 0 shares, with no pre-arranged 10b5-1 plan stated.

02

Market read

Traders may monitor for follow-on insider activity, but the filing alone does not change the company’s earnings or guidance outlook.

03

What to watch

The article does not clarify whether the sale was part of broader compensation/withholding mechanics, nor does it provide context on prior insider activity or total remaining holdings before the sale.

Relevance 6/10Novelty 3/10Timing: filed Aug 11 after Aug 10 sale trades

Background

This is an SEC Form 4 insider transaction disclosure for UFP Technologies, reported by Executive Chairman Bailly R. Jeffrey.

Company-level read

Ticker impact

$UFPTNeutralMedium confidence
Context

UFP Technologies disclosed an insider Form 4 showing Executive Chairman Bailly sold about $4.11M of UFPT shares via an open-market sale.

Expected impact

Likely limited near-term impact; any reaction would be sentiment-driven rather than based on new company performance data.

Evidence & confidence

Form 4 insider sales are common and the article provides no accompanying earnings, guidance, or operational change. The absence of a 10b5-1 plan can raise scrutiny, but the text does not link the sale to any specific event or outlook change.

Market effects

No clear sector read-through because the disclosure is company-specific and lacks operational or regulatory details.

None indicated.

None indicated.

Counterpoint

The sale could be purely liquidity or diversification related, especially since the filing shows multiple small trades and no stated company-specific reason.

Key entities

  • UFP Technologies Inc

    Subject of the Form 4 insider sale disclosure.

  • Bailly R. Jeffrey

    Executive Chairman and reporter of the Form 4 sale.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$UFPTMed

UFP Technologies (UFPT) Shares Just Moved, So What Is Driving Attention Now?

UFP Technologies (UFPT) reported Q3 sales of $172.43M and net income of $20.62M, up from the previous year. Shares rose 17.66% to $329.82 on the news, extending a 15.32% 7-day return. Analysts see a fair value of $355, citing growth in medical device components and packaging. However, UFPT trades at 33.4x earnings, higher than the industry average of 23.9x, raising valuation concerns.

$UFPTMed

UFP Technologies (UFPT) Q3 2026 Earnings Call Transcript

UFP Technologies (UFPT) reported Q3 2026 sales up 11.6%, with organic growth at 11.1%. Gross margin improved to 29.4% from 27.7% last year. Adjusted EPS was $2.88, up significantly. The company is investing in growth, including acquisitions like CI Medical, and expanding credit facilities. AJR operations are behind schedule but expected to improve in 2027. Management remains optimistic about long-term growth and shareholder value.

$UFPTHighAI 8/10

UFP Technologies (NASDAQ:UFPT) delivers impressive Q3 2026

UFP Technologies (UFPT) reported Q3 2026 revenue of $172.4M, up 11.6% YoY and 3.2% above estimates. Adjusted EPS of $2.88 beat estimates by 7.3%. Operating margin held steady at 16%. The company cited operational improvements and growth in new programs. Analysts expect 5.6% revenue growth over the next 12 months.

$UFPTHigh

UFP Technologies Announces Strong Q3 Results

UFP TECHNOLOGIES INC (UFPT) filed an SEC Form 8-K — Results of Operations and Financial Condition. UFP Technologies Announces Strong Q3 Results Newburyport, Mass., November 3, 2026. UFP Technologies, Inc. (Nasdaq: UFPT), a trusted contract development and manufacturing organization specializing in comprehensive solutions for medical devices, sterile packaging and other highly